Rapamycin: Anti-Fungal Agent Enhances Longevity
T
The Tim Ferriss Show featuring Dr. Peter Attia
Story of claim
Rapamycin, discovered in the 1960s on Easter Island, is FDA-approved for organ transplants. It shows potential to extend lifespan due to its anti-proliferative properties.
- Goal: Enhance longevity and improve organ transplant outcomes.
- Proof: Rapamycin suppresses immune response, aiding organ transplantation. It's tested for longevity enhancement.
- Nuances:
- Discovered on Easter Island in the 1960s.
- FDA-approved in 1999 for organ transplantation.
- Part of NIH's Interventions Testing Program.
- Impact on Life: Potential to extend lifespan and improve health outcomes.
Investments
- Price: Development and testing costs unspecified.
- Time: Decades of research since the 1960s.
- Effort: Significant scientific and medical effort.
Risks
Potential side effects; broader longevity implications under study.
Get Started 🚀
- Consult with a healthcare provider about its use.
- Understand its current applications in organ transplantation.
Brogevity AI can make mistakes. Check important info.